Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
134.72
+10.25 (8.23%)
At close: May 14, 2026, 4:00 PM EDT
137.99
+3.27 (2.43%)
After-hours: May 14, 2026, 6:12 PM EDT
Celcuity Market Cap
Celcuity has a market cap or net worth of $6.51 billion as of May 14, 2026. Its market cap has increased by 1,433.66% in one year.
Market Cap
6.51B
Enterprise Value
6.45B
1-Year Change
1,433.66%
Ranking
Category
Stock Price
$134.72
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $6.51B, an increase of 4,763.27%. That is a compound annual growth rate of 56.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 6.02B | 30.37% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Techne | 7.01B |
| Kymera Therapeutics | 6.96B |
| Mirum Pharmaceuticals | 6.78B |
| Protagonist Therapeutics | 6.78B |
| Spyre Therapeutics | 6.56B |
| Rhythm Pharmaceuticals | 6.43B |
| Apogee Therapeutics | 6.29B |
| Corcept Therapeutics | 6.25B |